By leveraging epigenetics and detecting gene dysregulation, Inherent Biosciences develops innovative diagnostics and therapeutics for complex diseases like infertility, autoimmune disease, and autism. Their epigenetic platform pioneers a new category of tools that provide personal insights into biology, enabling doctors to guide patients effectively. With a focus on pain management, embryo quality, COVID-19, and more, Inherent Biosciences aims to transform the way we diagnose and treat complex diseases. Their first product, Path Fertility, addresses infertility issues and can be found at pathfertility.com.